Analysts Buy the Dip, Slash Software Targets

Upgrades outnumbered downgrades across the week of October 12, with contrarian calls dominating in beaten-down tech, healthcare, and financials. The most striking single-stock story was VRNS, which absorbed six downgrades in a single day. Wells Fargo ran the most active sector rotation, slashing ADBE while lifting TYL in the same session.

---

Key Rating Changes

Upgrades

Technology

• CRM: B of A Securities (Tal Liani) lifted to Buy from Underperform, target up 78% to $285. One of the most dramatic rating reversals of the week.
• TYL: Wells Fargo upgraded to Overweight, target to $400 from $335, implying 21% upside.
• MANH: Morgan Stanley lifted to Overweight, target $250. Analyst sees 39% upside from prior levels.
• ZETA: Goldman Sachs upgraded to Buy, target raised 50% to $45, citing AI data-cloud positioning.
• ASTS: Deutsche Bank moved to Buy with a $93 target, implying 83% upside. Piper Sandler took the opposite view the next day, cutting to Neutral with a target of $54.
• WDAY: Keybanc downgraded to Sector Perform from Overweight.

Healthcare

• BIIB: JP Morgan lifted to Overweight, target raised 43% to $300.
• REGN: UBS upgraded to Buy, target $978, implying 26% upside.
• IONS: UBS raised to Buy with a 91% target increase to $88 from $46. Stock was trading near a 14-month low.
• LQDA: BTIG initiated at Buy with a $70 target, implying 161% upside. LifeSci Capital followed with an Outperform, consensus target now implies 78% upside.
• HUM: Raymond James upgraded to Outperform, target $520.
• FSLR: Truist raised to Buy, target lifted to $270 from $229, implying 52% upside from $178.

Financials and Industrials

• BAC: Baird upgraded to Outperform, target maintained at $62. Stock had fallen 18% in a month.
• ZION: Baird lifted to Outperform, target $75. Down 10% in a month.
• SLM: Morgan Stanley upgraded to Overweight, target to $30 from $28.
• ALSN: Citigroup raised to Buy with a $135 target, 23% implied upside.
• GXO: Goldman Sachs upgraded to Buy, target $61 versus a stock price of $46.50.
• TT: Goldman Sachs upgraded to Buy with a $565 target, 18% implied upside.
• ECHO: JP Morgan moved to Overweight from Underweight, target $144. Stock short interest sits at 17.8% of free float.
• HUBG: Baird (Daniel Moore) upgraded to Outperform, target maintained at $29. Stock down 28.6% in a month.
• RAL: Seaport Global raised to Buy, $88 target. Analyst cites a $1B defense backlog and the highest book-to-bill since 2022.
• HXL: Seaport also upgraded to Buy with a $104 target. Defence segment momentum cited.
• AEP: Keybanc lifted to Overweight, target $133. EXC also received a Keybanc upgrade to Sector Weight.
• REXR: Mizuho lifted to Outperform, target $41.
• PLD: Scotiabank upgraded to Sector Outperform, target $150.

Consumer

• KMX: BofA raised to Buy from Underperform, target $65 from $50, 30% implied upside.
• BWA: Bank of America lifted to Buy, target $85, implying 45% upside.
• EAT: Jefferies upgraded Brinker International to Buy, target $255. Raymond James followed with a Strong Buy.
• TXRH: Jefferies and Stephens both upgraded during the week. Jefferies to Buy, Stephens to Overweight.
• VFC: Piper Sandler and Truist both upgraded to Overweight, both setting a $20 target. Truist cited Vans turnaround signals.
• CROX: Barclays lifted to Overweight, target up 18% to $139.
• OLLI: Gordon Haskett upgraded to Buy, $105 target, 21.5% implied upside.
• WMT: Deutsche Bank raised to Buy, target $136 from $113.
• FOXA: BofA lifted to Buy, target up 57% to $85. World Cup tailwind and live sports advertising cited.

---

Downgrades

Technology

• ADBE: Double-downgraded during the week. Wells Fargo cut from Overweight to Underweight, target $225. HSBC dropped to Hold, target $267.
• VRNS: Six firms cut ratings on a single day (October 16). Needham, Rosenblatt, DA Davidson, Wells Fargo, Jefferies, Piper Sandler, and RBC all moved to Neutral or equivalent. Targets clustered at $49.75. The stock was at $47.34.
• HUBS: Barclays cut to Equal-Weight, target held at $240.
• MNDY: Barclays also cut to Equal-Weight, target $100.
• WDAY: Keybanc moved to Sector Perform from Overweight.
• KVYO: Goldman Sachs cut to Neutral, target down 26% to $20.
• NTAP: Barclays downgraded to Equal-Weight. Stock up 20% in a month on AI momentum.
• DELL: Barclays cut to Equal-Weight, target $574 from $603.
• HPE: Barclays downgraded to Equal-Weight, target $77 from $83.

Healthcare and Biopharma

• INSM: Wolfe Research downgraded to Peer Perform from Outperform.
• ROIV: Wolfe Research also cut to Peer Perform.
• ACAD: UBS dropped to Neutral, target slashed 53% to $23 from $49.
• LNTH: Mizuho cut to Neutral, target $109 from $115.
• ALGN: Baird downgraded to Neutral, target cut 26% to $162.
• NVST: Baird cut to Neutral, target $26 from $34. China pricing pressure cited.

Financials and Industrials

• ALLY: Morgan Stanley cut to Equal-Weight, target down 22% to $43. Margin pressure in consumer auto lending cited.
• ACGL: Morgan Stanley cut to Equal-Weight, target $100 from $105.
• EFX: Oppenheimer downgraded to Perform. Multiple other firms cut targets in the same week.
• SHC: JP Morgan cut to Underweight, target $17. Short interest up 25% in a month.
• BRKR: JP Morgan downgraded to Neutral, target $60. Short interest at 8.2% of free float.
• LII: Goldman Sachs cut to Neutral, target down 29% to $390.
• CARR: Goldman Sachs downgraded to Neutral, target cut to $61 from $74.
• ACI: BofA cut to Underperform, target $12. JP Morgan followed with a Neutral.
• ACT: JP Morgan moved to Underweight, target $44.
• EMN: JP Morgan cut to Neutral, target down 19.5% to $66.
• FMC: Jefferies downgraded to Hold, target cut 64%.
• SPOT: StoneX cut to Hold, citing streaming economics caution.
• GDDY: RBC cut to Sector Perform from Outperform, target $95.

---

Sector Themes

Software under coordinated pressure. The VRNS situation was the most concentrated analyst action of the week. Six separate firms issued downgrades on October 16 alone, all landing near a $49.75 target. That kind of clustering typically signals a pre-earnings reset rather than a new fundamental view. ADBE faced its own dual-downgrade from Wells Fargo and HSBC. Barclays ran a broad technology sweep, cutting HUBS, MNDY, NTAP, DELL, and HPE in the same week.

Defence and industrials attracting contrarian upgrades. Seaport Global backed HXL and RAL in the same week. Goldman Sachs upgraded TT and GXO. The theme is strengthening order books and backlog visibility. JP Morgan's jump from Underweight to Overweight on ECHO, a two-notch move, was among the most aggressive calls of the week.

Consumer dining gets fresh attention. Jefferies upgraded EAT and TXRH on the same day. Raymond James followed on EAT with a Strong Buy. The restaurant sector appears to be attracting buy-the-dip calls after recent price declines.

Healthcare split between upgrades and cuts. JP Morgan's 43% target raise on BIIB and UBS's 91% target jump on IONS were among the most aggressive positive revisions of the week. Against that, Wolfe Research cut two names in the same session and UBS slashed ACAD's target by more than half.

Utilities gaining analyst support. Keybanc upgraded both AEP and EXC. The moves reflect renewed interest in regulated utilities with visible rate structures, a theme consistent with broader interest rate positioning.